What was Argent Biopharma’s price range in the past 12 months?
Argent Biopharma lowest stock price was <$0.01 and its highest was $1.40 in the past 12 months.
What is Argent Biopharma’s market cap?
Currently, no data Available
When is Argent Biopharma’s upcoming earnings report date?
Argent Biopharma’s upcoming earnings report date is Aug 28, 2024 which is in 36 days.
How were Argent Biopharma’s earnings last quarter?
Argent Biopharma released its earnings results on Feb 29, 2024. The company reported -$20.483 earnings per share for the quarter, missing the consensus estimate of N/A by -$20.483.
Argent Biopharma does not currently pay dividends.
What is Argent Biopharma’s EPS estimate?
Argent Biopharma’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Argent Biopharma have?
Argent Biopharma has 48,405,600 shares outstanding.
What happened to Argent Biopharma’s price movement after its last earnings report?
Argent Biopharma reported an EPS of -$20.483 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 11.538%.
Which hedge fund is a major shareholder of Argent Biopharma?
Currently, no hedge funds are holding shares in RGTLF
MGC Pharmaceuticals Ltd is a European-based specialist Medical Cannabis company, in Phytocannabinoid-based medicine within the biopharmaceutical industry. The company's principal business goal is to produces and supply quality Cannabinoid based pharmaceutical products for the emergent medical markets in Europe, North America and Australasia.